A major contract from Apple could be on the horizon for Intel, representing one of the semiconductor industry’s most coveted prizes. This potential deal to manufacture Apple’s processors is generating intense speculation, yet it comes with significant caveats that may determine the future of the struggling chipmaker. As market experts oscillate between optimism and doubt, a critical question emerges: is this the transformative catalyst Intel needs, or merely a temporary boost?
Concrete Investment Amidst Speculation
Beyond the swirl of rumors, Intel has announced a tangible strategic move. Following a meeting between Intel CEO Lip-Bu Tan and Malaysian Prime Minister Anwar Ibrahim, the company confirmed a $208 million investment to expand its assembly and testing capabilities in Malaysia. This commitment signals a clear effort to diversify Intel’s global supply chain and reduce regional dependencies. For shareholders, it is an indication that management is pursuing long-term growth initiatives despite current operational headwinds.
Analyst Report Fuels Possibility of Landmark Deal
The source of the recent speculation is a report from TF International Securities analyst Ming-Chi Kuo, renowned for his accurate forecasts regarding Apple’s supply chain. According to his latest research, Intel could begin production for Apple as early as the second half of 2027, focusing on entry-level models of the Apple M-series chips. The technical prerequisites, specifically the Process Design Kit (PDK), are projected to be ready by early 2026.
Should investors sell immediately? Or is it worth buying Intel?
The significance of such an agreement cannot be overstated. Even if the initial production volume remains modest compared to Apple’s primary supplier TSMC, the symbolic value would be immense. Securing Apple as a client is considered a major endorsement, serving as a powerful signal that Intel’s manufacturing technology is once again competitive. This credibility is precisely what CEO Tan requires to revitalize the company’s faltering foundry business.
Divergent Wall Street Views Highlight Uncertainty
The investment community is deeply divided on Intel’s prospects. This schism is evident in the wide range of price targets issued by analysts. Rosenblatt Securities maintains a cautious stance with a $25 target, warning of persistent structural challenges. In stark contrast, Tigress Financial sees a path to $52 per share, contingent on the successful execution of the foundry strategy. The current consensus estimate sits near $35, notably below the recent trading level around $40.
This disparity underscores a fundamental market dilemma: equity prices appear to be factoring in the success of an unconfirmed Apple deal that remains years from potential fruition. The bullish thesis only materializes if Intel can deliver on its technological roadmaps between 2026 and 2027. Until then, the stock represents a high-risk bet on a promised turnaround that has yet to be realized.
Ad
Intel Stock: Buy or Sell?! New Intel Analysis from December 2 delivers the answer:
The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 2.
Intel: Buy or sell? Read more here...
